A guide to events on our campuses.

Assembly Series

A tradition of convening thought leaders since 1953

McKelvey School of Engineering

From Discovery of a New Drug to a Digital Center of Excellence for Chronic Itch

Thursday, September 17 | 4:00 PM - 4:45 PM

Based on the original discovery in the Kim Lab at WashU that Janus kinase (JAK) signaling in neurons critically mediates itch, Brian Kim and Duke Leahey co-founded Nuogen Pharma to develop JAK inhibitors for itch by way of a novel route of delivery. Currently, there are no FDA-approved medications specifically for chronic itch. Beyond treatments, recognizing the highly unmet need for patients in terms of diagnosis, education, management, and access, Kim and Duke decided to start an online digital center of excellence called SootheRx. This platform aims to revolutionize and innovate the delivery of care itself while simultaneously bringing new treatments to patients with chronic itch in the most effective and efficient manner possible.

Event Type

Lectures & Presentations, Research


School of Medicine


Business & Entrepreneurship, Medicine & Health



Institute of Clinical and Translational Sciences
Event Contact

Tina Hoffman | tina.hoffman@wustl.edu.

Speaker Information

Brian Kim, MD, Associate Professor of Dermatology at Washington University School of Medicine

Duke Leahey, CEO of SootheRX 

Google Calendar iCal Outlook